Mengmeng Ma, MD

Jinan, Shan Dong Provin

Disclosures:

• Employment: none
• Compensation: :Role Topic Description-End Date:
• Ownership: none
• Leadership: none

Presentation(s):

• 1138 - Bcl-2 Inhibitor Combined with Radiotherapy and Anti-Tumor Immune Response through Inducing Immunogenic Cell Death

  Wednesday, October 2, 2024
  10:40 AM – 10:45 AM ET